Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Other Non Operating Income (2016 - 2025)

Harte Hanks has reported Other Non Operating Income over the past 15 years, most recently at -$140000.0 for Q4 2025.

  • Quarterly Other Non Operating Income rose 39.39% to -$140000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, up 29.39% year-over-year, with the annual reading at -$1.1 million for FY2025, 50.92% up from the prior year.
  • Other Non Operating Income was -$140000.0 for Q4 2025 at Harte Hanks, down from -$106000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $4.7 million in Q3 2022 and troughed at -$2.6 million in Q1 2023.
  • The 5-year median for Other Non Operating Income is -$307000.0 (2023), against an average of -$168350.0.
  • Year-over-year, Other Non Operating Income soared 720.98% in 2022 and then plummeted 6730.77% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $70000.0 in 2021, then tumbled by 1967.14% to -$1.3 million in 2022, then dropped by 26.47% to -$1.7 million in 2023, then skyrocketed by 86.03% to -$231000.0 in 2024, then surged by 39.39% to -$140000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Other Non Operating Income are -$140000.0 (Q4 2025), -$106000.0 (Q3 2025), and -$386000.0 (Q2 2025).